Out Come Study To Define Laboratory Parameters That Are Best Suited to Diagnose Functional Iron Deficiency
NCT00495781 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 77
Last updated 2007-07-03
Summary
The purpose of the study is to define laboratory parameters which are best suited to diagnose functional iron deficiency. Functional iron deficiency is a condition where - due to the lack of iron bioavailability - the patient suffers from symptoms such as fatigue and weakness, or his/her capacity to produce red blood cells is reduced.
Conditions
- Functional Iron Deficiency
Interventions
- PROCEDURE
-
%-hypo (laboratory parameter, functional iron deficiency)
- PROCEDURE
-
CHr (laboratory parameter, functional iron deficiency)
- PROCEDURE
-
RET-HE (laboratory parameter, functional iron deficiency)
Sponsors & Collaborators
-
Viollier Inc.
collaborator OTHER -
Spital Zollikerberg
lead OTHER
Principal Investigators
-
Boris E Schleifenbaum, MD · Viollier Inc.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-10-31
- Completion
- 2006-05-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Study of the Prevalence of Iron Deficiency in Elderly Patient in Hospital Environment
NCT05514951 ·Status: COMPLETED ·Phase: NA
-
Short-Term Effects & Safety of an Accelerated Intravenous Iron Regimen in Patients With Heart Failure
NCT01925703 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Evaluation of Iron Treatment Efficiency Among Non-anemic But Iron-deficient Female Blood Donors
NCT00689793 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of Low-dose Iron Treatment in Non-anaemic Iron-deficient Women
NCT04636060 ·Status: COMPLETED ·Phase: NA
-
Effect of IV Iron in Patients With Heart Failure With Preserved Ejection Fraction
NCT03074591 ·Status: COMPLETED ·Phase: PHASE4
-
Differential Gene Expression in Patients With Heart Failure and Iron Deficiency - Effects of Ferric Carboxymaltose
NCT01978028 ·Status: TERMINATED ·Phase: PHASE4
-
Using Stable Iron Isotopic Techniques and Serum Hepcidin Profiles to Optimize Iron Supplementation
NCT01785407 ·Status: COMPLETED ·Phase: NA
-
Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality
NCT03036462 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure
NCT01394562 ·Status: COMPLETED ·Phase: PHASE3
-
Donor Iron Deficiency Study - Red Blood Cells From Iron-deficient Donors: Recovery and Storage Quality
NCT02889133 ·Status: COMPLETED ·Phase: NA
-
Iron Long-Term Labelling Study Switzerland
NCT02979132 ·Status: UNKNOWN ·Phase: NA
-
IRONHEART: Intravenous Iron in Non-ischaemic Heart Failure
NCT06542822 ·Status: RECRUITING
-
Assessing the Immediate Increase in Serum Ferritin After Oral Iron Doses: an Experimental Study in Iron-deficient Women
NCT06851130 ·Status: RECRUITING ·Phase: NA
-
Intravenous Versus Oral Iron in Late Pregnancy: Results of Treatment
NCT00746551 ·Status: COMPLETED ·Phase: PHASE4
-
Intravenous Iron Sucrose for Acute Decompensated Heart Failure Patients With Reduced Ejection Fraction and Iron Deficiency
NCT06703411 ·Status: COMPLETED ·Phase: PHASE4
-
Cardiac Function in Patients With Hereditary Hemochromatosis
NCT00068159 ·Status: COMPLETED
-
The Iron Content of Ferritin in Serum and Urine of Children With High Serum Ferritin Levels
NCT03777904 ·Status: TERMINATED
-
The Optimization of Bioavailability From Iron Supplements: Study 2
NCT02177851 ·Status: COMPLETED ·Phase: NA
-
Impact of Intravenous Iron on Musculoskeletal Function in Older Adults
NCT05708170 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid Phenotypes
NCT00102245 ·Status: TERMINATED
-
Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
NCT01131624 ·Status: COMPLETED ·Phase: PHASE3
-
Iron Homoeostasis in Inflammation
NCT02155114 ·Status: COMPLETED
-
Characteristics of Patients With Hypersensitivity Reactions to Intravenous Iron Infusions
NCT04359368 ·Status: COMPLETED
-
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study
NCT03037931 ·Status: COMPLETED ·Phase: PHASE3
-
Iron Supplementation in Heart Failure Patients With Anemia: The IRON-HF Study
NCT00386126 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3